Expanding Treatment Options in Relapsed/Refractory Follicular Lymphoma:
Exploring the Role of Epigenetics
This Learning Center is a freely accessible educational platform for healthcare providers who see patients with follicular lymphoma (FL). Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information for the treatment of patients with FL.
We encourage you to share this educational resource with your colleagues and your healthcare team.
Courses
Current Paradigms and Challenges for the Treatment of Relapsed and Refractory Follicular Lymphoma
Credit Available: 0.50 AMA PRA Category 1 Credits™
This activity will discuss current guidelines and therapy recommendations for R/R FL and specific challenges for those receiving multiple lines of therapy.
[Accreditation has expired. For informational purposes only.]
Course Faculty
Epigenetics and Follicular Lymphoma: Exploring Mechanisms of Pathology and New Treatment Targets
Credit Available: 0.50 AMA PRA Category 1 Credits™
This activity will review the physiological role of epigenetic modifying enzymes involved in the tumorigenesis of FL.
[Accreditation has expired. For informational purposes only.]
Course Faculty
Examining the Latest Data of Epigenetic Therapies in Follicular Lymphoma
Credit Available: 0.50 AMA PRA Category 1 Credits™
This activity will evaluate available efficacy and safety data for therapies targeting epigenetic pathways.
[Accreditation has expired. For informational purposes only.]
Course Faculty
Epigenetic Therapies in Practice: Exploring the Utility of New Therapies in Relevant Clinical Scenarios
Credit Available: 0.25 AMA PRA Category 1 Credits™
This activity will utilize clinical case studies to assess patient selection and practical management considerations regarding newer and emerging therapies used in R/R FL.
[Accreditation has expired. For informational purposes only.]